1Bergenheim AT.Radiosensitizing efect of estramustine in malignant glioma in vitro and in vivo[J].J Neorooncol,1994(23):191.
2Dehdashfi A R,Hegi M E,Regn L et al.New trends in the medical management of glioblastoma multiforme:the role of temozolomide chemotherapy[J].Neurosurg Focus.2006,20 (4):E6.
3Balana C,Capellades J,Teixidor P,et al.Clinical course of highgrade glioma patients with a " biopsy-only " surgical approach:a need for individualised treatment[J].Clin Transl Oncol,2007,9(12):797-803.
4Weyebroc KA,Walbridges B,Pluta RM.et al.Selective opening of the bolld-tumor barrier by a nitric oxide donor and Long-term survival in rats with C6 gliomas[J].J Neumsurg,2003,99(4):728.
5PradosMD,Scholdsc JR,Fine HA,et al.Arandomized double-bilin Placebo-controlled phase 2 study of RMP-7 in combination with eaiboplatin administered intravenously for the treatment of recurrent malignant glioma[J].Neuro oncol,2003,5(2):96.
6Hegi M E,Diserens A C,Gorlia T,et al.MGMT gene silencing and benefit from temozolomide in glioblastoma[J].N Engl J Med,2005,(352):997-1003.
7Wolfgang Wick,Michael Platten,and Michael Weller[J].Neuro Oncology,2009,11 (1):69-79.
10Chang CH, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the muhidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer, 1983, 52:997-1007.
